Nvidia stock pared losses Monday as market turmoil overshadowed AI chip news during the Computex Taipei tech expo.
Regeneron Pharmaceuticals to Acquire 23andMe for $256M
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced today that it will acquire 23andMe for a purchase price of $256 million. 23andMe had filed for bankruptcy protection in March this year, while REGN was the sole bidder for its assets. REGN intends to acquire its Personal Genome Service, Total Health, and Research Services business line, together with its Biobank […]
Insider Monkey
•
1 hour ago
Coinbase stock has officially joined the S&P 500 in major milestone for company and crypto industry
Regeneron Pharmaceuticals agreed to buy DNA testing company 23andMe in a bankruptcy court auction, the company said Monday.
Stocks included in 22V Research's basket of GARP names included Nvidia and Micron.
All eyes remain on Nvidia's quarterly results this week.
Nvidia's $20 billion deal to buy Groq will help it compete with Google as its rival continues marketing its TPUs for large-scale…
Nvidia denied rumors that it's in talks to buy a large PC company, telling CNBC in a statement that it's "not engaged in…
